mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.6 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.08 |
0.6 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |